Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.2K | $3.5K | $0 | $113.5K | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $47.7K | $0 | $0 | $0 | $0 |
| Gross profit | $16.2K | $3.5K | $0 | $65.8K | $0 | $0 | $0 | $0 |
| Gross margin | 100.0% | 100.0% | — | 58.0% | — | — | — | — |
| R&D | $977.2K | $444.2K | $399.4K | $144.1K | $336.1K | $126.3K | $152.7K | $14.2K |
| Operating income | −$15.8M | −$14.3M | −$5.9M | −$4.1M | −$2.8M | −$887.0K | −$738.0K | −$1.2M |
| EBITDA | −$9.9M | −$9.5M | −$5.3M | −$7.3M | −$2.5M | $2.1M | $1.9M | −$643.0K |
| Net income | −$16.3M | −$19.5M | −$7.3M | −$8.2M | −$4.7M | $1.1M | $3.6M | −$5.8M |
| Net margin | -100722.4% | -563702.0% | — | -7202.6% | — | — | — | — |
| EPS (diluted) | -106.45 | -90.09 | -22.81 | -19.03 | -10.44 | 2.40 | 0.38 | -0.16 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds IMUN.
No tracked institution reports a position in IMUN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-05-06 | 1-for-1000reverse |
No one on the platform has traded IMUN yet.
| $8M |
| — |
| IPCIFIntellipharmaceutics International Inc. | $0.15 | — | $5M | — |
| MXDHFMDxHealth S.A. | $0.25 | -9.09% | $9M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$IMUX If we reach a solution to the political problems (spically with canada) before April, we might see $IMUN above 10
View on StockTwits ↗Immune Therapeutics, Inc. Files SEC Form 8-K $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/sec-filings/
View on StockTwits ↗Immune Therapeutics, Inc. Files SEC Form 10-Q $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/sec-filings/
View on StockTwits ↗Immune Therapeutics Sees Short Interest Increase from 100 shares to 300 shares. $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/short-
View on StockTwits ↗$IMUN $IMUND Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky https://www.stocktitan.net/news/IMUN/biostax-corp-announces-the-passing-of-esteemed-director-h-louis-62ryb6oi0hfn.html
View on StockTwits ↗$IMUN $IMUND Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV https://www.stocktitan.net/news/IMUN/biostax-corp-signs-collaboration-agreement-with-immgenuity-inc-to-cgg5uk7owzw1.html
View on StockTwits ↗Immune Therapeutics, Inc. Files SEC Form 10-Q $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/sec-filings/
View on StockTwits ↗$IMUN $IMUND Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH https://www.stocktitan.net/news/IMUN/biostax-corp-announces-the-fd-as-acceptance-of-three-investigational-cqfee1gpr89n.html
View on StockTwits ↗Immune Therapeutics Sees Short Interest Decrease from 200 shares to 100 shares. $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/short-
View on StockTwits ↗$IMUN [15s. delayed]: Issued Press Release on May 30, 09:00:00: Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare https://s.flashalert.me/eQ4mHi
View on StockTwits ↗$IMUN Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare https://www.stocktitan.net/news/IMUN/biostax-launches-growth-funding-round-to-revitalize-affordable-osrdygdxhshp.html
View on StockTwits ↗$PIII we smoking, let's get her trending.. $IMUN $XELA $HUDI $SCYX
View on StockTwits ↗$IMUN [15s. delayed] filed form 10-Q on May 12, 15:57:40 https://s.flashalert.me/6TDBC
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.